Saphra announces controlled compassionate access to ivermectin
By Kelly Jane Turner 
6m ago
Share this article:
ShareTweetShareShareShareEmailShare
Cape Town – The South African Health Products Regulatory Authority (Saphra) has announced that it will allow a controlled compassionate use of Ivermectin to treat Covid-19.
The health product regulator says it will unveil the access protocols for the drug in the coming days.
The announcement marks a shift in the position of Saphra who indicated that there must still be more comprehensive clinical trials done for full access to the drug to be allowed.
“We at Sahpra have considered all of this, and the approach that we will be taking going forward is that we will facilitate a controlled, compassionate, access program for Ivermectin. This does not mean that our position changes around the lack of availability of scientific data, but we had to as a regulator have very in-depth discussions around the context which we find ourselves in with the pandemic with limited options,” said saphra chief executive Dr Boitumelo Semete-Makokotlela.
*This is a developing story